EBV-associated post-transplantation B-cell lymphoproliferative disorder following allogenic stem cell transplantation for acute lymphoblastic leukaemia: tumor regression after reduction of immunosuppression - a case report

EBV-associated post-transplantation B-cell lymphoproliferative disorder following allogenic stem cell transplantation for acute lymphoblastic leukaemia: tumor regression after reduction of immunosuppression - a case report

<p>Abstract</p> <p>Epstein-Barr virus (EBV)-associated B-cell post-transplantation lymphoproliferative disorder (PTLD) is a severe complication following stem cell transplantation. This is believed to occur as a result of iatrogenic immunosuppression leading to a relaxation of T-ce...

Full description

Bibliographic Details
Main Authors:	Niedobitek Gerald, Schmitz Nicole, Pönisch Wolfram, Moll Alexander, Krenauer Alexander, Niederwieser Dietger, Aigner Thomas
Format:	Article
Language:	English
Published:	BMC 2010-03-01
Series:	Diagnostic Pathology
Online Access:	http://www.diagnosticpathology.org/content/5/1/21

Similar Items

Refractory Epstein-Barr Virus (EBV)-Related Post-transplant Lymphoproliferative Disease: Cure by Combined Brentuximab Vedotin and Allogeneic EBV-Specific T-Lymphocytes
by: Thomas Mika, et al.
Published: (2019-12-01)

Role of allogeneic haematopoietic stem cell transplantation in the treatment of adult acute lymphoblastic leukaemia in the era of immunotherapy
by: Huang, X., et al.
Published: (2022)

Pre-transplantation Risks and Transplant-Techniques in Haematopoietic Stem Cell Transplantation for Acute Leukaemia
by: Alois Gratwohl, et al.
Published: (2019-10-01)

Allogeneic hematopoietic stem cell transplantation in patients with advanced indolent lymphoproliferative disorders
by: Ana Marcela Rojas Fonseca-Hial, et al.
Published: (2016-06-01)

Immunosuppressant indulges EBV reactivation and related lymphoproliferative disease by inhibiting Vδ2+ T cells activities after hematopoietic transplantation for blood malignancies
by: Jiangying Liu, et al.
Published: (2020-06-01)

Central nervous system post-transplant lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation: The Nagasaki transplant group experience
by: Hikaru Sakamoto, et al.
Published: (2019-01-01)

Allogeneic stem Cell Transplantation outcome in acute Lymphoblastic Leukemia Patients
by: Kamran Alimoghaddam, et al.
Published: (2015-10-01)

Allogeneic stem Cell Transplantation outcome in acute Lymphoblastic Leukemia Patients
by: Kamran Alimoghaddam, et al.
Published: (2012-10-01)

EBV-positive central nervous system lymphoproliferative disease associated with immunosuppression after organ transplantation: Long-term remission without chemotherapy
by: O A Gavrilina, et al.
Published: (2017-07-01)

Management of Epstein–Barr virus-related post-transplant lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation
by: Li Liu, et al.
Published: (2020-04-01)

Quantifying EBV-specific CD8⁺ T cell immunity in patients with post transplant lymphoproliferative disease (PTLD) and other EBV-driven malignancies
by: Guppy, Amy Elizabeth
Published: (2008)

CAR-T after Stem Cell Transplantation in B-Cell Lymphoproliferative Disorders: Are They Really Autologous or Allogenic Cell Therapies?
by: Ariadna Bartoló-Ibars, et al.
Published: (2021-09-01)

Nutritional Status at Diagnosis and Pre-transplant Weight Loss Impact Outcomes of Acute Myeloid Leukemia Patients Following Allogeneic Stem Cell Transplantation
by: Dominic Brauer, et al.
Published: (2021-03-01)

The application of minimal residual disease analysis in children and adolescents undergoing allogeneic bone marrow transplantation for acute lymphoblastic leukaemia
by: Knechtli, Christopher John Cranstoun
Published: (1999)

Case Report: Successful Chimeric Antigen Receptor T Cell Therapy in Haploidentical-Allogeneic Stem Cell Transplant Patients With Post-Transplant Lymphoproliferative Disorder
by: Nan Yan, et al.
Published: (2021-07-01)

Prognostic Impact of Blood MN1 Copy Numbers Before Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia
by: Madlen Jentzsch, et al.
Published: (2019-02-01)

Blastic Epstein-Barr virus associated post-transplant lymphoproliferative disorder after allogeneic stem cell transplantation for severe aplastic anemia
by: Masaaki Hotta, et al.
Published: (2018-05-01)

First case of near haploid philadelphia negative B-Cell acute lymphoblastic leukaemia relapsing as acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation
by: Claire Horgan, et al.
Published: (2020-01-01)

Immunosuppressive serum levels in allogeneic hematopoietic stem cell transplantation: pharmaceutical care contribution
by: Corrêa PM, et al.
Published: (2016-06-01)

ROLE OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
by: Federico Lussana, et al.
Published: (2014-10-01)

Allogeneic Haematopoietic Stem Cell Transplantation for Chronic Myeloid Leukaemia in the Era of Tyrosine Kinase Inhibitors
by: Ahmet Emre Eskazan, et al.
Published: (2018-08-01)

LYMPHOID NEOPLASMS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELLS TRANSPLANTATION. THE CASE OF SECONDARY HODGKIN’S LYMPHOMA, DIFFERENTIAL DIAGNOSIS WITH POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE
by: Yu. V. Skvortsova, et al.
Published: (2017-06-01)

Systemic EBV T-Cell Lymphoproliferative Disease of Young Adults
by: Zahedin Kheyri, et al.
Published: (2014-04-01)

Overview of EBV-Associated T/NK-Cell Lymphoproliferative Diseases
by: Hiroshi Kimura, et al.
Published: (2019-01-01)

Immune reconstitution in patients who have undergone stem cell transplantation for acute lymphoblastic leukaemia
by: Green, Ann Frances
Published: (2006)

Venetoclax in Combination with Decitabine for Relapsed T-Cell Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Cell Transplant
by: Leena T. Rahmat, et al.
Published: (2018-01-01)

EBV-positive post-transplant lymphoproliferative disorder presenting as primary diffuse large B-cell lymphoma of the central nervous system
by: Haoliang Xu, et al.
Published: (2017-09-01)

PRIMARY IMMUNOSUPPRESSION WITH TACROLIMUS AND AGE AT TRANSPLANTATION AS INDEPENDENT RISK FACTORS FOR THE DEVELOPMENT OF POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE IN CHILDREN UNDERGOING LIVER TRANSPLANTATION
by: GUTHERY, STEPHEN L.
Published: (2002)

EBV-Associated Lymphoproliferative Disorders
by: Young Hyeh Ko
Published: (2021-04-01)

CASE 2–2012: a 57-Year-Old Woman with Post-Transplant Lymphoproliferative Disorder after Allogeneic Stem Cell Transplantation for Primary Myelofibrosis
by: Milan Košťál, et al.
Published: (2012-01-01)

Molecular Diagnostics, Targeted Therapy, and the Indication for Allogeneic Stem Cell Transplantation in Acute Lymphoblastic Leukemia
by: Anthony Oyekunle, et al.
Published: (2011-01-01)

Prophylaxis and treatment of acute lymphoblastic leukemia relapse after allogeneic hematopoietic stem cell transplantation
by: Chen R, et al.
Published: (2015-02-01)

Immunosuppression-induced clonal T-cell lymphoproliferative disease causing severe diarrhoea mimicking coeliac disease following renal transplantation: a case report
by: Emily K. Glover, et al.
Published: (2020-06-01)

Challenges in Managing EBV-Associated T- and NK-Cell Lymphoproliferative Diseases
by: Yoshitaka Sato
Published: (2018-11-01)

Natural Killer Cells in Post-Transplant Lymphoproliferative Disorders
by: Cecilia Nakid-Cordero, et al.
Published: (2021-04-01)

Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice.
by: Nicole Caduff, et al.
Published: (2020-04-01)

Dissecting Epstein-Barr Virus-Specific T-Cell Responses After Allogeneic EBV-Specific T-Cell Transfer for Central Nervous System Posttransplant Lymphoproliferative Disease
by: Rebecca E. Schultze-Florey, et al.
Published: (2018-06-01)

Post-transplant lymphoproliferative disease
by: Nieto-Ríos, John Fredy, et al.
Published: (2016-07-01)

Regulatory T Cells in Allogeneic Stem Cell Transplantation
by: Maria Michael, et al.
Published: (2013-01-01)

Allogeneic Stem Cell Transplantation for MDS
by: Sara Villar, et al.
Published: (2021-08-01)